PLAUR and melanoma: Several studies support the relevance of the plasminogenactivator system in melanoma: urokinase plasminogen expression correlates with themetastatic potential of melanoma models, and the expression of urokinase plasminogenand its cognate receptor uPAR are increased in late-stage melanocytic tumors[43].